login

Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R.

Antiviral ResearchPublished 1 February 1982Open access
Alan P. Kendal, H. F. Maassab, G. I. Alexandrova, Yuri Ghendon
Citations79
View PDF

TL;DR

The ability to recombine influenza viruses by mixed infections during which the segmented RNA genome can reassort raised the prospect that once a suitable attenuated vaccine strain of influenza A was prepared, this property could be transferred to a new strain with contemporary HA and NA antigens.

Abstract

ts is used to designate viruses exhibiting >10 s loglo reduction in infectious titer at non-permissive temperatures of >38°C compared to titer at permissive temperature of 33-34°C.

Keywords

Immunology and MicrobiologyMedicine